Michel Prefontaine

Research

Read how they describe their research on their Western University profile.

Latest papers

Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process.
Journal of oncology · 2019
High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma.
Brachytherapy · 2016 · senior author
Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2016

All 6 publications

6 publications.

01

Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process.

McGee J, Peart TM, Foley N, Bertrand M, Prefontaine M, Sugimoto A, Ettler H, Welch S, Panabaker K

Journal of oncology2019

DOI: 10.1155/2019/6029097 PMID: 31061661

02

High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma.

Huang K, D'Souza D, Patil N, Velker V, Leung E, Stitt L, Whiston F, Sugimoto A, McGee J, Prefontaine M

Brachytherapy2016Senior author

DOI: 10.1016/j.brachy.2016.06.010 PMID: 27475479

03

Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?

Velker V, D'Souza D, Prefontaine M, McGee J, Leung E

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society2016

DOI: 10.1097/igc.0000000000000643 PMID: 26825823

04

CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience.

D'Souza D, Wiebe E, Patil N, Sugimoto A, Prefontaine M, Aulakh S, Whiston F, Stitt L, Surry K

Brachytherapy2014

DOI: 10.1016/j.brachy.2014.02.001 PMID: 24613570

05

Added-value of SPECT/CT to lymphatic mapping and sentinel lymphadenectomy in gynaecological cancers.

Belhocine TZ, Prefontaine M, Lanvin D, Bertrand M, Rachinsky I, Ettler H, Zabel P, Stitt LW, Sugimoto A, Urbain JL

American journal of nuclear medicine and molecular imaging2013

PMID: 23526734

06

Uterine smooth muscle tumors of uncertain malignant potential: diagnostic challenges and therapeutic dilemmas. Report of 2 cases and review of the literature.

Vilos GA, Marks J, Ettler HC, Vilos AG, Prefontaine M, Abu-Rafea B

Journal of minimally invasive gynecology2012

DOI: 10.1016/j.jmig.2011.12.025 PMID: 22546421

Frequent collaborators

Department of Obstetrics & Gynaecology
PATHOLOGY & LABORATORY MEDICINE, Western University
Clinical Pharmacology

Co-authors at Western University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Akira Sugimoto

Department of Obstetrics & Gynaecology

4 shared papers, latest 2019

Jacob McGee

Department of Obstetrics & Gynaecology

3 shared papers, latest 2019

Helen Ettler

PATHOLOGY & LABORATORY MEDICINE, Western University

2 shared papers, latest 2019

Monique Bertrand

Department of Obstetrics & Gynaecology

2 shared papers, latest 2019

Stephen Welch

Clinical Pharmacology

1 shared papers, latest 2019

Basim Abu Rafea

Department of Obstetrics & Gynaecology

1 shared papers, latest 2012

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Prefontaine, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process." (2019), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]